RYTM
Rhythm Pharmaceuticals, Inc.
Stock
$92.83−0.58 (−0.62%)Close Oct 2, 2026
- Capital expenditures, 2025
- $953K
- 5-year CAGR
- +34.8%
- 10-year CAGR
- +49.6%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $953K | — |
| 2024 | $0 | −100.0% |
| 2023 | $47K | −83.3% |
| 2022 | $281K | −35.3% |
| 2021 | $434K | +102.8% |
| 2020 | $214K | −93.7% |
| 2019 | $3.4M | +368.8% |
| 2018 | $722K | +442.9% |
| 2017 | $133K | −87.4% |
| 2016 | $1.1M | +6,117.6% |
| 2015 | $17K | — |